4//SEC Filing
YAU YI CHING 4
Accession 0000899243-20-031586
CIK 0001743881other
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 8:44 PM ET
Size
11.8 KB
Accession
0000899243-20-031586
Insider Transaction Report
Form 4
YAU YI CHING
Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2020-11-16$44.33/sh−1,900$84,227→ 4,586 total - Exercise/Conversion
Restricted Stock Units
2020-11-16−5,094→ 15,282 total→ Common Stock (5,094 underlying) - Exercise/Conversion
Common Stock
2020-11-16+5,493→ 6,486 total - Exercise/Conversion
Restricted Stock Units
2020-11-16−399→ 5,586 total→ Common Stock (399 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]Represents number of shares of the Issuer's Common Stock withheld to satisfy the Reporting Person's tax obligations in connection with the vesting of 5,493 shares of Common Stock underlying the Reporting Person's RSUs.
- [F3]The RSUs vest over approximately four years with a vesting commencement date of May 16, 2020 and have no expiration date. 6.25% of the RSUs vested on August 16, 2020 and November 16, 2020 an additional 6.25% will vest in quarterly installments on the 16th day of each February, May, August and November thereafter, subject to the Reporting Person's continued service with the Issuer or any of its subsidiaries through each vesting date.
- [F4]The RSUs vested as to 25% of the units on November 16, 2020 and as to 1/12th of the units each quarter thereafter for three additional years, subject to the Reporting Person's continuous service with the Issuer or any of its subsidiaries through each such vesting date, and have no expiration date.
Documents
Issuer
BridgeBio Pharma, Inc.
CIK 0001743881
Entity typeother
Related Parties
1- filerCIK 0001790097
Filing Metadata
- Form type
- 4
- Filed
- Nov 17, 7:00 PM ET
- Accepted
- Nov 18, 8:44 PM ET
- Size
- 11.8 KB